On May 16th, 2023, the POTENTIAL Consortium signed the Grant Agreement with the European Union (EU), setting an official milestone for the start of the project with all LSPs.
The project is born out of a concrete demand within the pharma supply chain to provide a hi-tech solution to tackle the problem of limited-supply and out-of-stock medicine.